Journal of Clinical Endocrinology & Metabolism, Vol 64, 730-736, Copyright © 1987 by Endocrine Society

ARTICLES

Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids

UH Stenman, H Alfthan, T Ranta, E Vartiainen, J Jalkanen and M Seppala

Serum hCG levels were measured in apparently healthy nonpregnant women and men using a highly sensitive and specific time-resolved immunofluorometric assay. The sensitivity of the assay was 0.03 IU/L. The levels were low in women of fertile age (median, 0.05 IU/L) and in men less than 60 yr of age (median, 0.04 IU/L). In women the median level increased to 1.1 IU/L after the menopause (range, 0.17-4.8 IU/L), and a similar but smaller increase occurred in men after 60 yr of age (median, 0.20 IU/L; range, less than 0.03-2.3). Stimulation with GnRH caused a 2- to 3-fold increase in the hCG level in both men and women. Chronic treatment of postmenopausal women with a combination of estrogen and progestagen lowered their serum hCG levels to about 50% of the pretreatment values. The hCG in serum could be separated from LH by gel chromatography, and the hCG immunoreactivity measured by direct assay of serum corresponded to the immunoreactivity eluted in the hCG fractions after gel chromatography. Thus, the results were not due to cross-reaction with LH. We conclude that serum of nonpregnant women and men contains hCG-like material, whose production is modulated by GnRH and sex steroids.

This article has been cited by other articles:

				A. M. Gronowski, C. R. Fantz, C. A. Parvin, L. J. Sokoll, C. L. Wiley, M. H. Wener, and D. G. Grenache Use of Serum FSH to Identify Perimenopausal Women with Pituitary hCG Clin. Chem., April 1, 2008; 54(4): 652 - 656. [Abstract] [Full Text] [PDF]

				C. R. McCudden, M. S. Willis, and D. G. Grenache Persistent Low Concentration of Human Chorionic Gonadotropin in a Nonpregnant Woman Clin. Chem., January 1, 2008; 54(1): 209 - 213. [Full Text] [PDF]

				A. Lempiainen, K. Hotakainen, C. Blomqvist, H. Alfthan, and U.-H. Stenman Increased Human Chorionic Gonadotropin Due to Hypogonadism after Treatment of a Testicular Seminoma Clin. Chem., August 1, 2007; 53(8): 1560 - 1561. [Full Text] [PDF]

				U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF]

				L. A. Cole "Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women Clin. Chem., October 1, 2005; 51(10): 1765 - 1766. [Full Text] [PDF]

				J. A. Snyder, S. Haymond, C. A. Parvin, A. M. Gronowski, and D. G. Grenache Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women Clin. Chem., October 1, 2005; 51(10): 1830 - 1835. [Abstract] [Full Text] [PDF]

				B. Couzinet, J. Pantel, P. Chanson, J. Young, S. Brailly, I. T. Huhtaniemi, J.-M. Bidart, and G. Schaison Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2293 - 2298. [Abstract] [Full Text]

				S G Ralph, A J Rutherford, and J D Wilson Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study BMJ, July 24, 1999; 319(7204): 220 - 223. [Abstract] [Full Text]

				L. A. Cole Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites Clin. Chem., December 1, 1997; 43(12): 2233 - 2243. [Abstract] [Full Text] [PDF]

				U.-H. Stenman, L. Unkila-Kallio, J. Korhonen, and H. Alfthan Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control Clin. Chem., July 1, 1997; 43(7): 1293 - 1298. [Abstract] [Full Text] [PDF]